What the analyst said

Oppenheimer analyst Ed Yang raised the price target on Lam Research (NASDAQ: LRCX) to $400.00 (from $330.00) while maintaining an Outperform rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

LRCX trades at $185. The 9 analysts who set a target in the last 3 months range from $290 to $400, with a median of $350. This $400 target is 14% above the median, the highest on the Street.

Since the note LRCX has moved −50% (from $367). 12-month window: day 143 of 365, closes on June 15, 2027.

Track record

This call✓ Target reached on June 22, 2026, 7 days after the note.

Firm track recordOppenheimer: 64% of its 14 targets at least a year old were reached within 12 months. Accuracy ranking →

Oppenheimer on Lam Research

Oppenheimer price targets on Lam Research

3 calls from January 29, 2026 to June 15, 2026. The target went from $265 to $400 (+51%). The rating stayed Buy.

Oppenheimer targetLRCX share price
  1. June 15, 2026 This noteTarget raised from $330 (+21%)Buy$400
  2. April 23, 2026Target raised from $265 (+25%)Buy$330
  3. January 29, 2026Earliest call shownBuy$265
Share

Other analysts on Lam Research

Lynx Equity Kept rating and price target Oct 28 $400maintained BernsteinBuy Cut price target −9%, kept rating Oct 22 $350from $385 UBSBuy Cut price target −6%, kept rating Oct 22 $400from $425 Morgan StanleyBuy Cut price target −12%, kept rating Oct 22 $339from $385 Bank of AmericaBuy Cut price target −10%, kept rating Oct 22 $345from $385
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.